Epidemiology of HR+/HER2- Breast CancerHR+ HER2- breast cancer is the most prevalent form of breast cancer, accounting for around 70% of all cases. Characterized by hormone receptor (HR) positivity and the absence of human epidermal growth factor receptor 2 (HER2) overexpression, this subtype exhibits varying prevalence across regions, with higher incidence rates observed in developed...